Loading chart…
CLOSED
ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, directly compressible granules, tablets, capsules, dry syrup, and oral thin films. The company offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements.
ZIM Laboratories Limited (ZIMLAB) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The ZIMLAB share price is ₹140.30 (+4.19% today), with a market capitalisation of ₹8B and a price-to-earnings (P/E) ratio of 171.1. MarketRipple tracks the ZIMLAB investment thesis, the ripple-chain impact of market events on ZIM Laboratories Limited, and the Healthcare sector outlook.
Open
₹136.68
High
₹143.45
Low
₹134.75
Prev. Close
₹134.66
52W High
₹159.81
52W Low
₹59.31
Day range
₹134.75–₹143.45
52-week range
₹59.31–₹159.81
Volume
37K
P/E
171.1
ROE
0.8%
D/E
0.43
Margin
0.5%
ZIM Laboratories Limited (NSE: ZIMLAB) is currently trading at ₹140.30 (+4.19%).
ZIM Laboratories Limited's market capitalization is ₹8B.
ZIM Laboratories Limited's price-to-earnings (P/E) ratio is 171.1.
ZIM Laboratories Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).